Evidence map›Paper›PMID 31363181›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

The development of the Clinician-reported Genetic testing Utility InDEx (C-GUIDE): a novel strategy for measuring the clinical utility of genetic testing.

R Z Hayeems, S Luca, W J Ungar, A Bhatt, L Chad, E Pullenayegum, M S Meyn

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Measuring perceived utility of genomic sequencing: Development and validation of the GENEtic Utility (GENE-U) scale for adult screening.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  11. Article
  12. Genetic Testing of Movements Disorders: A Review of Clinical Utility.Tremor and other hyperkinetic movements (New York, N.Y.) · 2024
    Review
  13. The Parent PrU: A measure to assess personal utility of pediatric genomic results.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Commentary on the development of the Clinician-reported Genetic testing Utility InDEx (C-GUIDE).Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

R Z HayeemsProgram in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada. robin.hayeems@sickkids.ca.ORCID http://orcid.org/0000-0003-3269-8004
S LucaProgram in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-1057-1013
W J UngarProgram in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-0762-0101
A BhattProgram in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-9134-8827
L ChadDivision of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON, Canada.ORCID http://orcid.org/0000-0003-0468-6663
E PullenayegumProgram in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada.
M S MeynCenter for Human Genomics and Precision Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Funding

Canadian Institutes of Health Research (CIHR) Project Grant PJT-152880
6 · The paper itself

Abstract

purposeClinical utility describes a genetic test's value to patients, families, health-care providers, systems, or society. This study aims to define clinical utility from the perspective of clinicians and develop a novel outcome measure that operationalizes this concept.

methodsItem selection for the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) was informed by a scoping review of the literature. Item reduction was guided by qualitative and quantitative feedback from semistructured interviews and a cross-sectional survey of genetics and nongenetics specialists. Final item selection, index scoring, and structure were guided by feedback from an expert panel of genetics professionals.

resultsA review of 194 publications informed the selection of a preliminary set of 25 items. Feedback from 35 semistructured interviews, 113 surveys, and 11 expert panelists informed the content and wording of C-GUIDE's final set of 18 items that reflect on the utility of testing related to diagnosis, management, and familial/psychosocial impact. C-GUIDE achieves content and face validity for use in a range of diagnostic genetic testing settings.

conclusionWork to establish reliability and construct validity is underway. C-GUIDE will be useful in comparative studies to generate policy-relevant evidence pertaining to the clinical utility of genetic testing across a range of settings.

Indexed as

Cross-Sectional StudiesEvidence-Based PracticeFemaleGenetic TestingHumansMaleOutcome Assessment, Health CareReproducibility of Resultsclinical utilityclinician perspectivemeasurement indexmixed methodsoutcomes research

Identifiers

PMID31363181
PMCPMC6944639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.